Identification of Δ-1-pyrroline-5-carboxylate derived biomarkers for hyperprolinemia type II
Open Access
- 21 September 2022
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 5 (1) , 1-8
Abstract
Hyperprolinemia type II (HPII) is an inborn error of metabolism due to genetic variants in ALDH4A1, leading to a deficiency in Δ-1-pyrroline-5-carboxylate (P5C) dehydrogenase. This leads to an accumulation of toxic levels of P5C, an intermediate in proline catabolism. The accumulating P5C spontaneously reacts with, and inactivates, pyridoxal 5’-phosphate, a crucial cofactor for many enzymatic processes, which is thought to be the pathophysiological mechanism for HPII. Here, we describe the use of a combination of LC-QTOF untargeted metabolomics, NMR spectroscopy and infrared ion spectroscopy (IRIS) to identify and characterize biomarkers for HPII that result of the spontaneous reaction of P5C with malonic acid and acetoacetic acid. We show that these biomarkers can differentiate between HPI, caused by a deficiency of proline oxidase activity, and HPII. The elucidation of their molecular structures yields insights into the disease pathophysiology of HPII.Keywords
This publication has 23 references indexed in Scilit:
- Addressing Protein–Protein Interactions with Small Molecules: A Pro‐Pro Dipeptide Mimic with a PPII Helix Conformation as a Module for the Synthesis of PRD‐Binding LigandsAngewandte Chemie International Edition, 2010
- In Vitro Reconstitution of the First Steps of Anatoxin-a Biosynthesis in Oscillatoria PCC 6506: From Free l-Proline to Acyl Carrier Protein Bound DehydroprolineBiochemistry, 2009
- N-(pyrrole-2-carboxyl) glycine a diagnostic marker of hyperprolinaemia type II: Mass spectra of trimethylsilyl derivativesClinica Chimica Acta, 2009
- High urinary excretion of N-(pyrrole-2-carboxyl) glycine in type II hyperprolinemiaClinical Genetics, 2008
- Pyridoxal Phosphate De-activation by Pyrroline-5-carboxylic AcidJournal of Biological Chemistry, 2001
- Fits, pyridoxine, and hyperprolinaemia type IIArchives of Disease in Childhood, 2000
- Mutations in the Delta1-pyrroline 5-carboxylate dehydrogenase gene cause type II hyperprolinemiaHuman Molecular Genetics, 1998
- An Assay for Pyrroline 5-Carboxylate Based on its Interaction with CysteineAnalytical Letters, 1991
- Type II hyperprolinaemia in a pedigree of Irish travellers (nomads).Archives of Disease in Childhood, 1989
- Enzymic Interconversion of Δ'-Pyrroline-5-carboxylic Acid and Related Amino Acids. I. A Modified Method of Determination of Δ'-Pyrroline-5-carboxylic AcidChemical and Pharmaceutical Bulletin, 1971